Design, synthesis, and biological evaluation of novel triazoloquinazolinone derivatives as SHP2 protein inhibitors
A novel series of triazoloquinazolinone derivatives were designed, synthesised, and evaluated for their in vitro biological activities against the SHP2 protein. Moreover, some compounds were evaluated against A375 cells. The results revealed that target compounds possessed moderate to excellent inhi...
Saved in:
Main Authors: | Rongshuang Luo, Zhongyuan Wang, Dali Luo, Yumei Qin, Chunshen Zhao, Di Yang, Tian Lu, Zhixu Zhou, Zhuyan Huang |
---|---|
Format: | article |
Language: | EN |
Published: |
Taylor & Francis Group
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/f6b4e6f2b10c48e0b8e1d41569278350 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Molecular features underlying differential SHP1/SHP2 binding of immune checkpoint receptors
by: Xiaozheng Xu, et al.
Published: (2021) -
Thyroid cancer MR molecular imaging via SHP2-targeted nanoparticles
by: Hu Z, et al.
Published: (2019) -
Discriminating between competing models for the allosteric regulation of oncogenic phosphatase SHP2 by characterizing its active state
by: Paolo Calligari, et al.
Published: (2021) -
Biological evaluation of novel 6-Arylbenzimidazo [1,2-c] quinazoline derivatives as inhibitors of LPS-induced TNF- alpha secretion
by: GALARCE,GLORIA D, et al.
Published: (2008) -
The abnormal activation of D1R/Shp-2 complex involved in levodopa-induced dyskinesia in 6-hydroxydopamine-lesioned Parkinson’s rats
by: Wu N, et al.
Published: (2018)